STOK Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $7,426,002.60

Stoke Therapeutics Insider Trading History Chart

Stoke Therapeutics Share Price & Price History

^$32.62

▲ +2.14 (7.02%)

As of 02/6/2026 02:53 PM ET

Days: 30 | 90 | 365

Stoke Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/8/2025	Edward M. Kaye	Director	Sell	13,430	$32.27	$433,386.10	49,124
12/8/2025	Jonathan Allan	General Counsel	Sell	3,978	$32.28	$128,409.84	11,831
12/5/2025	Barry Ticho	Insider	Sell	3,662	$31.34	$114,767.08	19,798
12/5/2025	Edward M. Kaye	Director	Sell	8,548	$31.32	$267,723.36	62,554
12/5/2025	Jonathan Allan	General Counsel	Sell	8,785	$31.29	$274,882.65	15,809
12/4/2025	Barry Ticho	Insider	Sell	1,696	$30.87	$52,355.52	23,460
12/4/2025	Edward M. Kaye	Director	Sell	6,453	$30.87	$199,204.11	71,102
12/4/2025	Jonathan Allan	General Counsel	Sell	1,018	$30.87	$31,425.66	24,594
12/3/2025	Barry Ticho	Insider	Sell	2,014	$30.65	$61,729.10	15,156
12/3/2025	Edward M. Kaye	Director	Sell	1,070	$30.65	$32,795.50	51,305
12/3/2025	Jonathan Allan	General Counsel	Sell	2,292	$30.65	$70,249.80	19,612
12/2/2025	Barry Ticho	Insider	Sell	2,006	$29.78	$59,738.68	17,170
12/2/2025	Edward M. Kaye	Director	Sell	1,066	$29.78	$31,745.48	52,375
12/2/2025	Jonathan Allan	General Counsel	Sell	2,284	$29.78	$68,017.52	21,904
11/14/2025	Adrian R Krainer	Director	Sell	40,472	$26.98	$1,091,934.56	364,246
11/3/2025	Barry Ticho	Insider	Sell	5,931	$25.72	$152,545.32	7,195
10/8/2025	Edward M. Kaye	Director	Sell	25,000	$30.00	$750,000.00	49,124
10/3/2025	Edward M. Kaye	Director	Sell	42,461	$25.09	$1,065,346.49	49,124
10/3/2025	Jonathan Allan	General Counsel	Sell	10,000	$25.07	$250,700.00	11,831
9/3/2025	Edward M. Kaye	Director	Sell	45,996	$20.13	$925,899.48	91,585
9/3/2025	Jonathan Allan	General Counsel	Sell	6,345	$20.07	$127,344.15	11,831
9/2/2025	Barry Ticho	Insider	Sell	5,501	$19.87	$109,304.87	18,469
9/2/2025	Edward M. Kaye	Director	Sell	14,860	$20.14	$299,280.40	137,581
9/2/2025	Jonathan Allan	General Counsel	Sell	14,922	$20.14	$300,529.08	18,176
8/29/2025	Edward M. Kaye	Director	Sell	1,029	$20.00	$20,580.00	152,441
8/29/2025	Jonathan Allan	General Counsel	Sell	850	$20.00	$17,000.00	23,948
8/13/2025	Jonathan Allan	General Counsel	Sell	13,712	$15.00	$205,680.00	19,631
8/1/2025	Barry Ticho	Insider	Sell	4,504	$12.82	$57,741.28	16,775
6/3/2025	Barry Ticho	Insider	Sell	6,471	$10.03	$64,904.13	25,782
6/2/2025	Barry Ticho	Insider	Sell	1,745	$10.00	$17,450.00	32,253
3/18/2025	Barry Ticho	Insider	Sell	3,884	$8.67	$33,674.28	63,962
3/18/2025	Edward M. Kaye	Director	Sell	10,382	$8.67	$90,011.94	148,253
3/18/2025	Jonathan Allan	General Counsel	Sell	2,266	$8.67	$19,646.22	33,510
12/9/2024	Barry Ticho	Insider	Sell	2,586	$12.99	$33,592.14	44,746
12/9/2024	Edward M. Kaye	CEO	Sell	6,786	$12.99	$88,150.14	61,885
12/9/2024	Jonathan Allan	General Counsel	Sell	13,666	$13.61	$185,994.26	21,476
12/6/2024	Barry Ticho	Insider	Sell	13,945	$12.78	$178,217.10	47,332
12/6/2024	Edward M. Kaye	CEO	Sell	6,170	$12.78	$78,852.60	68,671
12/6/2024	Jonathan Allan	General Counsel	Sell	9,696	$12.78	$123,914.88	35,142
12/2/2024	Barry Ticho	Insider	Sell	10,000	$12.07	$120,700.00	51,277
9/19/2024	Skorpios Trust	Major Shareholder	Sell	1,937,500	$14.05	$27,221,875.00	8,906,181
7/1/2024	Barry Ticho	Insider	Sell	10,000	$13.75	$137,500.00	2,485
4/17/2024	Skorpios Trust	Major Shareholder	Sell	3,600,000	$11.60	$41,760,000.00	10,843,681
3/28/2024	Jonathan Allan	General Counsel	Sell	5,126	$13.20	$67,663.20	2,598
3/19/2024	Edward M. Kaye	CEO	Sell	11,150	$6.10	$68,015.00	69,350
3/19/2024	Jonathan Allan	General Counsel	Sell	2,349	$6.10	$14,328.90	7,724
3/19/2024	Stephen J Tulipano	CFO	Sell	4,116	$6.10	$25,107.60	20,746
2/1/2024	Barry Ticho	Insider	Sell	10,000	$4.80	$48,000.00	6,981
1/2/2024	Barry Ticho	Insider	Sell	10,000	$5.74	$57,400.00	16,981
7/3/2023	Barry Ticho	Insider	Sell	15,000	$10.60	$159,000.00	25,895
6/21/2023	Jonathan Allan	General Counsel	Sell	1,948	$13.48	$26,259.04
6/1/2023	Barry Ticho	Insider	Sell	15,000	$11.13	$166,950.00	40,895
5/3/2023	Barry Ticho	Insider	Sell	24,697	$10.14	$250,427.58	56,548
5/1/2023	Barry Ticho	Insider	Sell	24,967	$10.00	$249,670.00	86,758
2/6/2023	Barry Ticho	Insider	Sell	9,235	$10.02	$92,534.70	111,725

SEC Filings (Institutional Ownership Changes) for Stoke Therapeutics (NASDAQ:STOK)

Institutional Buying and Selling by Quarter

Stoke Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/6/2026	PSP Research LLC	16,621	$0.53M	0.5%	N/A	0.029%
2/6/2026	Profund Advisors LLC	33,388	$1.06M	0.0%	N/A	0.058%
2/6/2026	ProShare Advisors LLC	10,721	$0.34M	0.0%	+11.4%	0.019%
2/4/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	6,550	$0.21M	0.0%	N/A	0.011%
2/4/2026	Swiss Life Asset Management Ltd	6,798	$0.22M	0.0%	N/A	0.012%
2/3/2026	Privium Fund Management B.V.	55,000	$1.75M	0.3%	N/A	0.096%
2/2/2026	Hussman Strategic Advisors Inc.	63,000	$2M	0.5%	N/A	0.110%
2/2/2026	Strs Ohio	7,000	$0.22M	0.0%	+9.4%	0.012%
1/29/2026	UBS Group AG	169,713	$5.39M	0.0%	-44.5%	0.297%
1/29/2026	Vanguard Group Inc.	3,149,239	$99.96M	0.0%	-0.5%	5.513%
1/29/2026	Generali Investments Management Co LLC	2,471	$78K	0.0%	+41.0%	0.004%
1/29/2026	China Universal Asset Management Co. Ltd.	12,907	$0.41M	0.0%	+34.4%	0.023%
1/28/2026	Arizona State Retirement System	10,936	$0.35M	0.0%	-3.2%	0.019%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	2,776	$88K	0.0%	+31.1%	0.005%
1/23/2026	Baillie Gifford & Co.	246,900	$7.84M	0.0%	N/A	0.432%
1/22/2026	Massachusetts Financial Services Co. MA	19,101	$0.61M	0.0%	N/A	0.033%
1/15/2026	Allspring Global Investments Holdings LLC	24,462	$0.76M	0.0%	-30.2%	0.043%
1/9/2026	SG Americas Securities LLC	25,836	$0.82M	0.0%	+187.2%	0.045%
1/9/2026	Assenagon Asset Management S.A.	1,227,723	$38.97M	0.1%	+36.4%	2.149%
1/1/2026	JPMorgan Chase & Co.	24,376	$0.57M	0.0%	-5.0%	0.043%
11/17/2025	Jacobs Levy Equity Management Inc.	15,085	$0.35M	0.0%	-87.8%	0.026%
11/17/2025	CANADA LIFE ASSURANCE Co	11,978	$0.30M	0.0%	+12.3%	0.021%
11/17/2025	Polar Capital Holdings Plc	1,323,470	$31.10M	0.1%	+49.8%	2.317%
11/17/2025	Palo Alto Investors LP	105,427	$2.48M	0.5%	-16.2%	0.185%
11/17/2025	Parkman Healthcare Partners LLC	250,000	$5.88M	0.6%	N/A	0.438%
11/17/2025	Nomura Holdings Inc.	81,209	$1.91M	0.0%	N/A	0.142%
11/17/2025	Millennium Management LLC	61,048	$1.44M	0.0%	+199.3%	0.107%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	50,463	$1.19M	0.0%	-5.5%	0.088%
11/17/2025	Jain Global LLC	24,340	$0.57M	0.0%	N/A	0.043%
11/17/2025	Granahan Investment Management LLC	253,899	$5.97M	0.2%	-52.3%	0.445%
11/17/2025	Checkpoint Capital L.P.	212,049	$4.98M	1.7%	N/A	0.371%
11/17/2025	Bank of America Corp DE	249,451	$5.86M	0.0%	-54.5%	0.437%
11/17/2025	Ameriprise Financial Inc.	20,996	$0.49M	0.0%	N/A	0.037%
11/14/2025	Schonfeld Strategic Advisors LLC	238,015	$5.59M	0.0%	+36.2%	0.417%
11/14/2025	Creative Planning	43,304	$1.02M	0.0%	-2.1%	0.076%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	75,858	$1.78M	0.0%	-29.3%	0.133%
11/14/2025	Wellington Management Group LLP	737,753	$17.34M	0.0%	+438.2%	1.292%
11/13/2025	Platinum Investment Management Ltd.	32,901	$0.77M	0.0%	N/A	0.058%
11/13/2025	Marshall Wace LLP	768,287	$18.06M	0.0%	-66.6%	1.345%
11/13/2025	Invesco Ltd.	208,075	$4.89M	0.0%	+417.5%	0.364%
11/13/2025	Sei Investments Co.	16,450	$0.39M	0.0%	N/A	0.029%
11/13/2025	UBS Group AG	306,037	$7.19M	0.0%	-13.2%	0.536%
11/13/2025	BNP Paribas Financial Markets	13,401	$0.32M	0.0%	+220.1%	0.023%
11/13/2025	Franklin Resources Inc.	115,833	$2.72M	0.0%	+42.3%	0.203%
11/13/2025	Legal & General Group Plc	37,783	$0.89M	0.0%	+21.6%	0.066%
11/13/2025	Vestcor Inc	10,171	$0.24M	0.0%	N/A	0.018%
11/13/2025	Russell Investments Group Ltd.	3,831	$90K	0.0%	-75.7%	0.007%
11/13/2025	Dynamic Technology Lab Private Ltd	13,630	$0.32M	0.1%	N/A	0.024%
11/13/2025	Rhenman & Partners Asset Management AB	250,000	$5.88M	0.7%	N/A	0.438%
11/13/2025	First Trust Advisors LP	152,299	$3.58M	0.0%	N/A	0.267%
11/12/2025	Barclays PLC	107,723	$2.53M	0.0%	-23.0%	0.189%
11/12/2025	Dimensional Fund Advisors LP	678,307	$15.95M	0.0%	+0.7%	1.188%
11/12/2025	Cresset Asset Management LLC	32,795	$0.77M	0.0%	N/A	0.057%
11/12/2025	Kennondale Capital Management LLC	69,732	$1.64M	1.3%	+14.0%	0.122%
11/12/2025	Rafferty Asset Management LLC	35,327	$0.83M	0.0%	-31.3%	0.062%
11/12/2025	Generali Investments Management Co LLC	1,753	$41K	0.0%	N/A	0.003%
11/12/2025	Intech Investment Management LLC	13,147	$0.31M	0.0%	-27.8%	0.023%
11/10/2025	China Universal Asset Management Co. Ltd.	9,605	$0.23M	0.0%	-12.4%	0.017%
11/7/2025	GSA Capital Partners LLP	47,583	$1.12M	0.1%	+22.5%	0.083%
11/7/2025	Vanguard Group Inc.	3,163,874	$74.35M	0.0%	+7.4%	5.539%
11/7/2025	JPMorgan Chase & Co.	24,376	$0.57M	0.0%	-5.0%	0.043%
11/6/2025	Rhumbline Advisers	68,304	$1.61M	0.0%	+2.8%	0.125%
11/6/2025	ProShare Advisors LLC	9,622	$0.23M	0.0%	-7.9%	0.018%
11/5/2025	Alps Advisors Inc.	44,664	$1.05M	0.0%	+51.8%	0.082%
11/4/2025	Penserra Capital Management LLC	150,599	$3.54M	0.0%	N/A	0.275%
11/4/2025	State of Wyoming	7,844	$0.18M	0.0%	N/A	0.014%
11/4/2025	Principal Financial Group Inc.	45,205	$1.06M	0.0%	N/A	0.082%
11/3/2025	AlphaQuest LLC	15,095	$0.36M	0.0%	+139.9%	0.028%
11/3/2025	Arizona State Retirement System	11,294	$0.27M	0.0%	N/A	0.021%
11/3/2025	New York State Common Retirement Fund	15,035	$0.35M	0.0%	+41.4%	0.027%
10/30/2025	Strs Ohio	6,400	$0.15M	0.0%	N/A	0.012%
10/29/2025	Skorpios Trust	2,256,181	$53.02M	99.7%	-30.7%	4.117%
10/28/2025	Campbell & CO Investment Adviser LLC	30,418	$0.72M	0.1%	N/A	0.056%
10/23/2025	SG Americas Securities LLC	8,996	$0.21M	0.0%	N/A	0.016%
10/23/2025	KLP Kapitalforvaltning AS	9,600	$0.23M	0.0%	-27.3%	0.018%
10/20/2025	Allspring Global Investments Holdings LLC	35,058	$0.82M	0.0%	-1.0%	0.064%
10/7/2025	Assenagon Asset Management S.A.	900,272	$21.16M	0.0%	+67.3%	1.643%
9/26/2025	Corient Private Wealth LLC	659,834	$7.49M	0.0%	N/A	1.204%
9/4/2025	Osaic Holdings Inc.	7,488	$85K	0.0%	+263.3%	0.014%
8/15/2025	Tower Research Capital LLC TRC	4,370	$50K	0.0%	+461.0%	0.008%
8/15/2025	Corient Private Wealth LLC	659,834	$7.49M	0.0%	N/A	1.204%
8/15/2025	Rafferty Asset Management LLC	51,458	$0.58M	0.0%	-16.6%	0.094%
8/15/2025	Opaleye Management Inc.	562,120	$6.38M	1.3%	+87.4%	1.026%
8/15/2025	Lazard Asset Management LLC	13,832	$0.16M	0.0%	N/A	0.025%
8/15/2025	Gilder Gagnon Howe & Co. LLC	129,571	$1.47M	0.0%	+22.4%	0.236%
8/15/2025	Engineers Gate Manager LP	33,276	$0.38M	0.0%	N/A	0.061%
8/15/2025	BNP Paribas Financial Markets	4,186	$48K	0.0%	+66.2%	0.008%
8/15/2025	Bank of America Corp DE	548,090	$6.22M	0.0%	+2.9%	1.000%
8/14/2025	MPM Bioimpact LLC	789,698	$8.96M	1.6%	+13.8%	1.441%
8/14/2025	Jane Street Group LLC	34,743	$0.39M	0.0%	+28.8%	0.064%
8/14/2025	Redmile Group LLC	4,375,931	$49.67M	5.3%	-2.5%	8.015%
8/14/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	53,411	$0.61M	0.0%	+121.0%	0.098%
8/14/2025	The Manufacturers Life Insurance Company	15,099	$0.17M	0.0%	+14.1%	0.028%
8/13/2025	Marshall Wace LLP	2,300,554	$26.11M	0.0%	+7.9%	4.214%
8/13/2025	Invesco Ltd.	40,207	$0.46M	0.0%	+53.6%	0.074%
8/13/2025	Virtus Investment Advisers LLC	7,955	$90K	0.0%	-40.3%	0.015%
8/13/2025	Advantage Alpha Capital Partners LP	17,888	$0.20M	0.1%	N/A	0.033%
8/13/2025	Kennondale Capital Management LLC	61,183	$0.69M	0.7%	+45.3%	0.112%
8/12/2025	American Century Companies Inc.	27,339	$0.31M	0.0%	N/A	0.050%
8/12/2025	Rhumbline Advisers	66,419	$0.75M	0.0%	+33.9%	0.122%

Data available starting January 2016

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary targeted augmentation of nuclear gene output to develop antisense oligonucleotides to selectively restore protein levels. Its lead clinical candidate is STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy. The company also develops STK-001, which is in phase I/II clinical trial to treat Dravet syndrome; and programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye. The company has a license and collaboration agreement with Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of severe and rare genetic neurodevelopmental diseases of the central nervous system. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.

Today's Range

Now: $32.62

$31.06

$33.48

50 Day Range

MA: $31.43

$28.70

$35.22

52 Week Range

Now: $32.62

$5.35

$38.69

Volume

323,775 shs

Average Volume

715,490 shs

Market Capitalization

$1.86 billion

P/E Ratio

48.44

Dividend Yield

N/A

Beta

1.1

Who are the company insiders with the largest holdings of Stoke Therapeutics?: Stoke Therapeutics' top insider shareholders include:
Skorpios Trust (Major Shareholder)
Adrian R Krainer (Director)
Edward M Md Kaye (Director)
Edward M Md Kaye (CEO)
Barry Ticho (Insider)
Jonathan Allan (General Counsel)
Stephen J Tulipano (CFO)
Learn More about top insider investors at Stoke Therapeutics.
Who are the major institutional investors of Stoke Therapeutics?: Stoke Therapeutics' top institutional shareholders include:
Vanguard Group Inc. — 5.51%
Assenagon Asset Management S.A. — 2.15%
Baillie Gifford & Co. — 0.43%
UBS Group AG — 0.30%
Hussman Strategic Advisors Inc. — 0.11%
Privium Fund Management B.V. — 0.10%
Learn More about top institutional investors of Stoke Therapeutics stock.
Which institutional investors are selling Stoke Therapeutics stock?: During the last quarter, STOK stock was sold by these institutional investors:
UBS Group AG
Vanguard Group Inc.
Allspring Global Investments Holdings LLC
Arizona State Retirement System
During the last year, company insiders that have sold Stoke Therapeutics company stock include:
Skorpios Trust (Major Shareholder)
Adrian R Krainer (Director)
Edward M Md Kaye (Director)
Edward M Md Kaye (CEO)
Learn More investors selling Stoke Therapeutics stock.
Which institutional investors are buying Stoke Therapeutics stock?: In the last quarter, STOK stock was purchased by institutional investors including:
Assenagon Asset Management S.A.
Baillie Gifford & Co.
Hussman Strategic Advisors Inc.
Privium Fund Management B.V.
Profund Advisors LLC
Massachusetts Financial Services Co. MA
SG Americas Securities LLC
Swiss Life Asset Management Ltd